US$ 21.89
clinical trial semaglutide AHA 2024: continues to impress in diabetic kidney disease Semaglutide: The Drug of Today
Description
Canonical and non-canonical autophagy: variations on a common theme of self-eating

Such results raise the possibility that semaglutide may influence systems tied not only to metabolism, but also to mood regulation and behavioral control

Oh JH, et al

On the other hand, microglia could also drive tau spreading and toxicity by promoting neuroinflammation, such as activating NACHT-, LRR- and pyrin (PYD)-domain-containing protein 3 (NLRP3) inflammasome 155 or inducing NF-kB signaling
This study aimed to evaluate the prognostic significance of GLP1R expression on overall survival across various cancer types

[DOI] [PubMed] [Google Scholar] 889.Diabetes Prevention Program Research Group
